New

From idea to ETF portfolio in minutes. Build yours now →

Advertisement
Advertisement

PINKvsIBBETF Comparison

ETF 1
PINK

Simplify Health Care ETF

This fund is part of
Healthcare Technology
+0.13%
VS
ETF 2
IBB

iShares Biotechnology ETF

This fund is part of
US Health Care
+0.95%

Simplify Health Care ETF (PINK) belongs to the Healthcare Technology segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. PINK's top 3 sector exposures are Healthcare, Non-Energy Materials and Consumer Cyclicals. In contrast, IBB's top sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. PINK is more expensive with a Total Expense Ratio (TER) of 0.51%, versus 0.44% for IBB. PINK is up 7.82% year-to-date (YTD) with +$8M in YTD flows. IBB performs better with 26.78% YTD performance, and +$196M in YTD flows. Run a side-by-side ETF comparison of PINK and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PINK vs IBB performance and flow charts

Performance

051015%Aug 3Aug 10Aug 17Aug 24Aug 31

Cumulative Flows

-100 M-50 M0 M50 M100 M150 M200 M250 MAug 3Aug 10Aug 17Aug 24Aug 31

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/01/2026
1M3MYTD1Y3Y5Y
Perf.
PINK
IBB
+0.27%+14.94%
+5.62%+30.26%
+7.82%+26.78%
+29.98%+52.59%
+52.03%+68.32%
n/a+23.12%
Flows
PINK
IBB
-$6M+$155M
+$92M+$611M
+$8M+$196M
+$190M+$1.69B
+$232M-$674M
--$1.57B
Volatility and drawdown
3M1Y3Y5Y
Volatility
PINK
IBB
+16.58%+24.84%
+18.04%+21.74%
+17.13%+21.02%
n/a+22.45%
Max drawdown
PINK
IBB
-4.76%-6.21%
-16.68%-9.61%
-18.81%-24.82%
n/a-39.67%
Max drawdown duration
PINK
IBB
33d31d
154d151d
390d377d
n/a1587d
Trading data

Create an account to view trading data

Join for free
PINK
IBB
Last sale
9/3/2026 at 1:30 PM
$39.85
$213.81
Previous close
09/02/2026
$39.70
$213.80
Consolidated volume
09/02/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

PINK
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PINK
IBB
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/3/2026 at 1:30 PM
Live
Closed
PINK
IBB
Last price
$39.85
$213.81
1D performance
+0.38%
+0.00%
AuM$374.30 M$10.72 B
E/R0.51%0.44%
Characteristics
PINK
IBB
Management strategyActivePassive
ProviderSimplifyiShares
Benchmark-ICE Biotechnology Index
N° of holdings49241
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateOctober 7, 2021February 5, 2001
ESGNoNo
Advertisement
Exposure

Countries

PINK
USA
86.58%
Denmark
7.14%
Other
6.29%
IBB
USA
86.04%
Other
13.96%

Sectors

PINK
Healthcare
87.2%
Other
12.8%
IBB
Healthcare
99.9%
Other
0.1%
Advertisement

Diversification

PINK

Total weight of top 15 holdings out of 15

72.03%
IBB

Total weight of top 15 holdings out of 15

54.48%

Top 15 holdings

Data as of July 31, 2026
PINK
Novo Nordisk A/S
7.14%
Thermo Fisher Scientific, Inc.
6.87%
United Therapeutics Corp.
6.82%
Purecycle Technologies, Inc.
5.19%
Johnson & Johnson
5.02%
Eli Lilly & Co.
5.01%
Jazz Pharmaceuticals Plc
4.98%
UnitedHealth Group, Inc.
4.88%
AbbVie, Inc.
4.71%
Warby Parker, Inc.
4.15%
10X Genomics, Inc.
3.83%
Danaher Corp.
3.50%
Biohaven Ltd.
3.33%
Benitec Biopharma, Inc.
3.31%
Quest Diagnostics, Inc.
3.28%
IBB
Amgen, Inc.
8.42%
Vertex Pharmaceuticals, Inc.
7.87%
Gilead Sciences, Inc.
7.14%
Regeneron Pharmaceuticals, Inc.
5.84%
argenx SE
3.55%
Natera, Inc.
2.88%
Revolution Medicines, Inc.
2.87%
Illumina, Inc.
2.42%
Biogen, Inc.
2.38%
Alnylam Pharmaceuticals, Inc.
2.14%
BeOne Medicines Ltd.
2.01%
Incyte Corp.
1.91%
Insmed, Inc.
1.71%
United Therapeutics Corp.
1.69%
Moderna, Inc.
1.65%
Frequently asked questions about PINK and IBB

How have the PINK and IBB ETFs performed in 2026?

As of September 1, 2026, PINK is up 7.82% year-to-date (YTD), while IBB has returned 26.78%. That puts IBB better performer ahead so far this year.

Which ETF is attracting more investor money: PINK or IBB?

Year-to-date, the PINK ETF saw +$8M in flows, compared to +$196M for IBB.

Which ETF is more volatile: PINK or IBB?

Over the past year, PINK had a volatility of 18.04%, while IBB experienced 21.74%.

Which ETF is bigger: PINK or IBB?

As of September 1, 2026, PINK holds $374.30 M in assets under management (AUM), while IBB manages $10.72 B.

What sectors do the PINK and IBB ETFs invest in?

PINK leans toward sectors like Healthcare. Meanwhile, IBB focuses on Healthcare.

What are the top holdings of the PINK ETF and IBB ETF?

PINK top holdings include Novo Nordisk A/S, Thermo Fisher Scientific, Inc. and United Therapeutics Corp.. IBB holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc..

Which ETF is more diversified: PINK or IBB?

PINK holds 49 securities with 72.03% of its assets in the top 15. IBB has 241 securities and a top 15 weight of 54.48%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder